RxDoctor Payments Data

Yvonne Saunders-Teigeler, MD

Family Medicine · Las Vegas, NVNPI 1477534030

Payments from drug & device makers

$560in general payments, 2019–2025

Across 31 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Exact Sciences$115
  • Novo Nordisk$112
  • AstraZeneca$79
  • Boehringer Ingelheim$56
  • Lilly USA, LLC$54
  • GSK$49
  • plus $94 from 4 others

What the payments were for

  • Food & beverage$560100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$560 in reported general payments places this provider in the 60th percentile of 902 family medicine providers in Nevada.

See all family medicine providers in Nevada

Medicare billing

Part B allowed, 2024
$7,775
Medicare patients
24
Services billed
82

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide55$114,543
EliquisApixaban75$101,049
RybelsusSemaglutide38$76,959
OzempicSemaglutide50$76,386
JardianceEmpagliflozin42$63,460
Trelegy ElliptaFluticasone/Umeclidin/Vilanter33$54,401
JanuviaSitagliptin Phosphate26$42,235
FarxigaDapagliflozin Propanediol27$33,541
MyrbetriqMirabegron22$29,619
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$20,380
OxycontinOxycodone Hcl11$16,023
SymbicortBudesonide/Formoterol Fumarate19$7,760
Albuterol Sulfate HfaAlbuterol Sulfate153$5,365
Lantus SolostarInsulin Glargine,hum.Rec.Anlog40$5,073
Gabapentin252$4,032

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$112$153,34588 claims
Lilly USA, LLCMounjaro$54$114,54355 claims
PfizerEliquis$34$101,04975 claims
Boehringer IngelheimJardiance$56$63,46042 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$79$61,68161 claims
GSKTrelegy Ellipta$49$54,40133 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 902 family medicine providers in Nevada.

Other family medicine in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →